[Form 4] Argan, Inc Insider Trading Activity

Rhea-AI Filing Summary

Form 4 Filing Details: Peter W. Getsinger, Director of Argan (AGX), exercised stock options and acquired shares on June 23, 2025. Key transaction details:

• Exercised 10,000 stock options at $71.75 per share using net settlement method
• Options were originally awarded on January 5, 2017, with expiration date of January 5, 2027
• Acquired 6,465 common shares through this transaction
• Post-transaction holdings: 18,351 direct common shares and 34,500 remaining stock options

This insider transaction represents a standard option exercise by a board member, with the net settlement method resulting in fewer shares being issued than the original option amount due to covering the exercise cost.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Getsinger Peter W

(Last) (First) (Middle)

35 SNOWS POINT

(Street)

EDGARTOWN MA 02539

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2025		M		6,465(1)	A	$71.75	18,351	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$71.75	06/23/2025		M			10,000(1)	01/05/2018	01/05/2027	Common Stock	10,000	$71.75	34,500	D

Explanation of Responses:

1. On June 23, 2025 the Reporting Person exercised his stock option awarded on January 5, 2017 to purchase 10,000 shares of the Issuer's common stock at a price of $71.75 per share, using the net settle method.

	/s/ Peter W. Getsinger	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AGX stock options did Peter Getsinger exercise on June 23, 2025?

Peter Getsinger exercised 10,000 stock options of AGX common stock on June 23, 2025, at an exercise price of $71.75 per share using the net settle method.

What is Peter Getsinger's role at Argan Inc (AGX)?

According to the Form 4 filing, Peter W. Getsinger serves as a Director of Argan Inc (AGX), as indicated by the 'X' marked under the Director relationship field.

When were the AGX stock options originally granted to Getsinger?

The stock options were originally awarded to Peter Getsinger on January 5, 2017, with an expiration date of January 5, 2027.

How many shares of AGX does Peter Getsinger own after the stock option exercise?

Following the reported transaction, Peter Getsinger directly owns 18,351 shares of AGX common stock and continues to hold 34,500 stock options.

What was the exercise price of AGX stock options in this Form 4 filing?

The exercise price of the AGX stock options was $71.75 per share.